Generic versions of Novo Nordisk’s semaglutide begin to flow, priced 50-80% lower than the innovator

Seven major drugmakers announced the launch of their generic versions of semaglutide

Generic versions of Novo Nordisk’s semaglutide begin to flow, priced 50-80% lower than the innovator
Seven major drugmakers announced the launch of their generic versions of semaglutide

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Economist Admin Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.